Overbrook Management Corp Abbott Laboratories Transaction History

Overbrook Management Corp

$464 Million
Q4 2024

A detailed history of Overbrook Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Overbrook Management Corp holds 1,898 shares of ABT stock, worth $215,385. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,898

Previous 2,755 31.11%

Holding current value

$215,385

Previous $314,000 31.85%

% of portfolio

0.05%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$111.93 - $119.39 $95,924 - $102,317	-857 Reduced 31.11%	1,898 $214,000
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $143,700 - $169,634	-1,436 Reduced 34.26%	2,755 $314,000
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $395,695 - $437,028	-3,613 Reduced 46.3%	4,191 $476,000
Q4 2023 Feb 02, 2024	BUY	$90.19 - $110.4 $81,171 - $99,360	900 Added 13.04%	7,804 $858,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $85,864 - $95,671	-852 Reduced 10.99%	6,904 $752,000
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $29,639 - $34,887	-306 Reduced 3.8%	7,756 $785,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $3,232 - $3,791	-34 Reduced 0.42%	8,062 $885,000
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $14,514 - $16,804	-150 Reduced 1.82%	8,096 $783,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $61,752 - $74,638	-605 Reduced 6.84%	8,246 $896,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $98,200 - $120,241	850 Added 10.62%	8,851 $1.25 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $131,942 - $145,966	-1,131 Reduced 12.39%	8,001 $945,000
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $150,010 - $176,583	-1,418 Reduced 13.44%	9,132 $1.06 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $10,884 - $12,822	-100 Reduced 0.94%	10,550 $1.26 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $772,170 - $841,444	-7,354 Reduced 40.85%	10,650 $1.17 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $25,659 - $31,161	-280 Reduced 1.53%	18,004 $1.96 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $576,954 - $738,430	7,535 Added 70.1%	18,284 $1.67 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $46,172 - $67,517	735 Added 7.34%	10,749 $848,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $43,494 - $48,419	-554 Reduced 5.24%	10,014 $870,000
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $61,583 - $71,825	-845 Reduced 7.4%	10,568 $889,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $27,607 - $33,305	454 Added 4.14%	11,413 $837,000
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $5,699 - $6,290	-99 Reduced 0.9%	10,959 $668,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $10,972 - $12,405	-195 Reduced 1.73%	11,058 $663,000
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $24,156 - $25,861	-450 Reduced 3.85%	11,253 $642,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $562,446 - $627,748	11,703	11,703 $624,000

Others Institutions Holding ABT

# of Institutions

3,196

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Overbrook Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Overbrook Management Corp with notifications on news.

Account

Overbrook Management Corp Abbott Laboratories Transaction History